These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28719234)

  • 21. Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits.
    Hodges LC; Reggio PH; Green K
    Ophthalmic Res; 1997; 29(1):1-5. PubMed ID: 9112260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
    Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
    Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis Studies.
    Green HM; Fellner DMJ; Finlay DB; Furkert DP; Glass M
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid CB
    Li AL; Carey LM; Mackie K; Hohmann AG
    J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys.
    Chien FY; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2003 Jan; 121(1):87-90. PubMed ID: 12523891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
    Miller S; Daily L; Leishman E; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5904-5911. PubMed ID: 30550613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid-induced changes in respiration of brain mitochondria.
    Fišar Z; Singh N; Hroudová J
    Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of topical and intravenous administration of WIN 55-212-2 in normotensive rabbits.
    Samudre SS; Schneider JL; Oltmanns MH; Hosseini A; Pratap K; Loose-Thurman P; Allen RC; Williams PB; Lattanzio FA; Sheppard JD
    Curr Eye Res; 2008 Oct; 33(10):857-63. PubMed ID: 18853319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study.
    Mohammadi Vosough E; Baradaran Rahimi V; Masoud SA; Mirkarimi HR; Demneh MK; Abed A; Banafshe HR; Askari VR
    Life Sci; 2019 Sep; 232():116670. PubMed ID: 31330139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
    Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
    Clin Exp Ophthalmol; 2015; 43(1):54-66. PubMed ID: 24995479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative allosteric modulation of CB
    Iyer V; Rangel-Barajas C; Woodward TJ; Kulkarni A; Cantwell L; Crystal JD; Mackie K; Rebec GV; Thakur GA; Hohmann AG
    Pharmacol Res; 2022 Nov; 185():106474. PubMed ID: 36179954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
    Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
    Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.
    Sharif NA
    Curr Drug Targets; 2010 Aug; 11(8):978-93. PubMed ID: 20426763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
    Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
    Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1559-67. PubMed ID: 17505840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum.
    Donnerer J; Liebmann I
    Pharmacology; 2018; 101(5-6):330-336. PubMed ID: 29627825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cannabinoid applications in glaucoma].
    Pinar-Sueiro S; Rodríguez-Puertas R; Vecino E
    Arch Soc Esp Oftalmol; 2011 Jan; 86(1):16-23. PubMed ID: 21414525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A GPR18-based signalling system regulates IOP in murine eye.
    Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
    Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.